Form D — AirNexis Therapeutics, Inc.
0002116194-26-000001 · filed Mar 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $200,000,000
- Reported amount sold
- $62,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- AirNexis Therapeutics, Inc.
- CIK
- 2116194
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 1001 PAGE MILL ROAD
PALO ALTO, California 94304 - Phone
- (619) 604-7904
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Maria Fardis · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Anna Chen · DirectorPalo Alto, California Find on LinkedIn ↗
-
Evan Caplan · DirectorPalo Alto, California Find on LinkedIn ↗
-
Colin Walsh · DirectorPalo Alto, California Find on LinkedIn ↗
-
Jill Carroll · DirectorPalo Alto, California Find on LinkedIn ↗
-
James Li · Executive OfficerPalo Alto, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗